AZ's gMG drug Klygefa nears EU approval
AstraZeneca's rare disease unit Alexion has claimed a positive opinion from the EMA's human medicines committee for generalised myasthenia gravis (gMG) therapy Klygefa. The recommendation by the CHMP sets up an EU approval in the coming weeks for …